Patients receiving chlorthalidone had lower rates of major cardiovascular (CV) events and noncancer-related deaths vs those receiving hydrochlorothiazide. Currently, most US-based thiazide ...
BOSTON — The prominent headline from the highly anticipated Diuretic Comparison Project (DCP), published in late 2022, was that the antihypertensive drugs chlorthalidone and hydrochlorothiazide showed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback